IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Essex Woodlands Management, Inc.

Q2 2014 Holdings

Filed 2014-08-13 | 11 holdings | $480.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revance Therapeutics Inc(RVNCEUR)COM761330109$156.1K4,592,04732.5%
Horizon Pharma IncCOM44047T109$89.0K5,815,94018.5%
Abiomed Inc(ABMDEUR)COM003654100$79.2K3,150,00016.5%
Corium Intl IncCOM21887L107$72.7K9,353,30415.1%
Endologix IncCOM29266S106$60.1K2,814,93612.5%
Acura Pharmaceuticals IncCOM NEW00509L703$10.7K10,284,8862.2%
Ziopharm Oncology IncCOM98973P101$10.3K2,764,9082.1%
Medicinova Inc(MNOV)COM NEW58468P206$2.4K1,170,3700.5%
Curis IncCOM231269101$435233,7970.1%
Echo Therapeutics IncCOM NEW27876L206$2812,3190.0%
Palatin Technologies IncCOM PAR $ .01696077403$2423,9280.0%